Rockefeller Capital Management »

Matinas Biopharma Hldgs shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Matinas Biopharma Hldgs (MTNB) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Matinas Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Matinas Biopharma Hldgs held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Matinas Biopharma Hldgs by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $945 500 1.89

More positions owned by Rockefeller Capital Management

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
salesforce (CRM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Tidal Trust Iii Rockefeller Glob (RGEF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Tidal Trust Iii Rockefeller Us S (RSMC)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Rockefeller Capital Management

Top funds holding Matinas Biopharma Hldgs

Vanguard Group
Geode Capital Management
BlackRock
Sargent Investment Group
Holos Integrated Wealth
Renaissance Technologies
Northern Trust
State Street Corporation
Two Sigma Securities
Hrt Financial
Tower Research Capital
Rockefeller Capital Management
Farther Finance Advisors
Advisor Group Holdings
UBS Group

View all funds holding Matinas Biopharma Hldgs